First patients dosed in early trial of promising new cancer drug
Disease control
Recruiting now
This is the first-ever study in people of an experimental cancer drug called TJ101. The main goal is to find a safe dose and see how the body handles it. The study will also look for early signs that the drug can shrink tumors in adults with advanced cancers who have run out of s…
Phase: PHASE1 • Sponsor: Phrontline Biopharma • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC